Is India’s diagnostics sector poised for a long-term growth upswing? Axis Securities sees opportunity in three stocks

Axis Securities sees India’s diagnostics sector entering a multi-year growth upcycle, supported by rising demand, scalable models and strong cash generation. It initiated BUY coverage on Dr. Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services.

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to livemint.com's own reporting rather than reproducing it — the excerpt above comes from livemint.com's own feed.